✦ LIBER ✦

Impact of Cytogenetics and Marrow Remission Status on Disease Progression in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Undergoing Allogeneic Stem Cell Transplantation

✍ Scribed by E. Koca; R.M. Saliba; M. de Lima; U. Popat; P. Kebriaei; G. Rondon; W. Zhang; S. Giralt; B.A. Andersson; R. Champlin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of disease burden at time of allo

✍ Kebriaei, P; Kline, J; Stock, W; Kasza, K; Le Beau, M M; Larson, R A; van Besien 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 139 KB

Reduced-toxicity conditioning with treos

✍ Kröger, N; Shimoni, A; Zabelina, T; Schieder, H; Panse, J; Ayuk, F; Wolschke, C; 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 153 KB

Impact of Cytogenetics Risk on Outcome A

✍ M. Mohty; M. Labopin; N. Milpied; J.J. Cornelissen; D. Blaise; E. Petersen; N. T 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Myeloablative Reduced-Toxicity i.v. Busu

✍ Gheath Alatrash; Marcos de Lima; Nelson Hamerschlak; Matteo Pelosini; Xuemei Wan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 360 KB

Combining Azacitidine (Vidaza®, Aza) and

✍ T. Schroeder; A.G. Czibere; N. Kröger; U. Platzbecker; G. Bug; L. Uharek; T. Luf 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 63 KB